Skip to content

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Status
Suspended
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512927-36-00
Acronym
LOXO-LNC-24001
Enrollment
95
Registered
2024-08-19
Start date
2025-10-30
Completion date
Unknown
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or Metastatic Urothelial Carcinoma or Other Solid Tumors

Interventions

None listed

Sponsors

Eli Lilly & Co.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026